RHOB influences lung adenocarcinoma metastasis and resistance in a host-sensitive manner

Molecular Oncology

Volumn 8, Issue 2, 2014, Pages 196-206

  Luis Ravelo, Diego ^a   Antón, Iker ^a   Zandueta, Carolina ^a   Valencia, Karmele ^a   Pajares, María José ^a   Agorreta, Jackeline ^a   Montuenga, Luis ^a   Vicent, Silvestre ^a   Wistuba, Ignacio I ^b   De Las Rivas, Javier ^c   Lecanda, Fernando ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c CSIC   (Spain)

Author keywords

Chemotherapy; Drug target; GTPase; Microenvironment; MMP; Non cell autonomous; Radiotheraphy; Tumor stroma

Indexed keywords

CISPLATIN; GEMCITABINE; HISTONE DEACETYLASE 4; PACLITAXEL; RHOB GUANINE NUCLEOTIDE BINDING PROTEIN; STROMELYSIN; STROMELYSIN 2; COMPLEMENTARY DNA; GUANOSINE TRIPHOSPHATASE; LENTIVIRUS VECTOR; SHORT HAIRPIN RNA; SYNTHETIC PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METASTASIS; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RESISTANCE; CANCER SURVIVAL; CARCINOMA CELL; CHEMOSENSITIVITY; CONTROLLED STUDY; GAMMA IRRADIATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; LUNG ADENOCARCINOMA; MICROARRAY ANALYSIS; MOUSE; MULTIMODALITY CANCER THERAPY; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; A549 CELL LINE; CANCER CHEMOTHERAPY; CLONOGENIC ASSAY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME ASSAY; GENE EXPRESSION; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; TUMOR MICROENVIRONMENT; WESTERN BLOTTING;

MURINAE;

CHEMOTHERAPY; DRUG TARGET; GTPASE; MICROENVIRONMENT; MMP; NON-CELL AUTONOMOUS; RADIOTHERAPHY; TUMOR-STROMA;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; BRIDGED COMPOUNDS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; HETEROGRAFTS; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; RHOB GTP-BINDING PROTEIN; TAXOIDS;

EID: 84894356774     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2013.11.001     Document Type: Article

References (52)

1. Acharyya S., Oskarsson T., Vanharanta S., Malladi S., Kim J., Morris P.G., Manova-Todorova K., Leversha M., Hogg N., Seshan V.E., Norton L., Brogi E., Massague J. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell 2012, 150:165-178.
2. Ader I., Toulas C., Dalenc F., Delmas C., Bonnet J., Cohen-Jonathan E., Favre G. RhoB controls the 24 kDa FGF-2-induced radioresistance in HeLa cells by preventing post-mitotic cell death. Oncogene 2002, 21:5998-6006.
3. Ader I., Delmas C., Bonnet J., Rochaix P., Favre G., Toulas C., Cohen-Jonathan-Moyal E. Inhibition of Rho pathways induces radiosensitization and oxygenation in human glioblastoma xenografts. Oncogene 2003, 22:8861-8869.
4. Alfano D., Ragno P., Stoppelli M.P., Ridley A.J. RhoB regulates uPAR signalling. J. Cell Sci. 2012, 125:2369-2380.
5. Antón I., Luis-Ravelo E.M.D., Zandueta C., Valencia K., Ormazabal C., Martínez-Canarias S., Perurena N., Pajares M.J., Agorreta J., Montuenga L.M., Segura V., Wistuba I.I., De Las Rivas J., Hermida J., Lecanda F. Receptor of activated protein C promotes metastasis and correlates with clinical outcome in lung adenocarcinoma. Am. J. Resp. & Crit. Care Med. 2012, 186:96-105.
6. Bild A.H., Yao G., Chang J.T., Wang Q., Potti A., Chasse D., Joshi M.B., Harpole D., Lancaster J.M., Berchuck A., Olson J.A., Marks J.R., Dressman H.K., West M., Nevins J.R. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2006, 439:353-357.
7. Bousquet E., Mazieres J., Privat M., Rizzati V., Casanova A., Ledoux A., Mery E., Couderc B., Favre G., Pradines A. Loss of RhoB expression promotes migration and invasion of human bronchial cells via activation of AKT1. Cancer Res. 2009, 69(15):6092-6099.
8. Catena R., Luis-Ravelo D., Anton I., Zandueta C., Salazar-Colocho P., Larzabal L., Calvo A., Lecanda F. PDGFR signaling blockade in marrow stroma impairs lung cancer bone metastasis. Cancer Res. 2011, 71:164-174.
9. Couderc B., Pradines A., Rafii A., Golzio M., Deviers A., Allal C., Berg D., Penary M., Teissie J., Favre G. In vivo restoration of RhoB expression leads to ovarian tumor regression. Cancer Gene Ther. 2008, 15:456-464.
10. Du W., Prendergast G.C. Geranylgeranylated RhoB mediates suppression of human tumor cell growth by farnesyltransferase inhibitors. Cancer Res. 1999, 59:5492-5496.
11. Engel M.E., Datta P.K., Moses H.L. RhoB is stabilized by transforming growth factor beta and antagonizes transcriptional activation. J. Biol. Chem. 1998, 273:9921-9926.
12. Feld R., Rubinstein L.V., Weisenberger T.H. Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies. J. Clin. Oncol. 1984, 2:1352-1358.
13. Fernandez-Borja M., Janssen L., Verwoerd D., Hordijk P., Neefjes J. RhoB regulates endosome transport by promoting actin assembly on endosomal membranes through Dia1. J. Cell Sci. 2005, 118:2661-2670.
14. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 2003, 3:453-458.
15. Gan P.P., Pasquier E., Kavallaris M. Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer. Cancer Res. 2007, 67:9356-9363.
16. Ganji P.N., Nalla A.K., Gupta R., Mohanam S., Gujrati M., Dinh D.H., Rao J.S. siRNA-mediated downregulation of MMP-9 and uPAR in combination with radiation induces G2/M cell cycle arrest in medulloblastoma. Mol. Cancer Res. 2010, 9(1):51-66.
17. Goncalves A., Braguer D., Kamath K., Martello L., Briand C., Horwitz S., Wilson L., Jordan M.A. Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics. Proc. Natl. Acad. Sci. U S A 2001, 98:11737-11742.
18. Gupta G.P., Nguyen D.X., Chiang A.C., Bos P.D., Kim J.Y., Nadal C., Gomis R.R., Manova-Todorova K., Massague J. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 2007, 446:765-770.
19. Han H.J., Russo J., Kohwi Y., Kohwi-Shigematsu T. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 2008, 452:187-193.
20. Hess K.R., Varadhachary G.R., Taylor S.H., Wei W., Raber M.N., Lenzi R., Abbruzzese J.L. Metastatic patterns in adenocarcinoma. Cancer 2006, 106:1624-1633.
21. Hu G., Chong R.A., Yang Q., Wei Y., Blanco M.A., Li F., Reiss M., Au J.L., Haffty B.G., Kang Y. MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell 2009, 15:9-20.
22. Jaffe A.B., Hall A. Rho GTPases in transformation and metastasis. Adv. Cancer Res. 2002, 84:57-80.
23. Jaffe A.B., Hall A. Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 2005, 21:247-269.
24. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J. Clin. 2010, 60:277-300.
25. Jiang K., Sun J., Cheng J., Djeu J.Y., Wei S., Sebti S. Akt mediates Ras downregulation of RhoB, a suppressor of transformation, invasion, and metastasis. Mol. Cell Biol. 2004, 24:5565-5576.
26. Josson S., Sharp S., Sung S.Y., Johnstone P.A., Aneja R., Wang R., Gururajan M., Turner T., Chung L.W., Yates C. Tumor-stromal interactions influence radiation sensitivity in epithelial-versus mesenchymal-like prostate cancer cells. J. Oncol. 2010, 2010:10. Article ID 232831.
27. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 2009, 9:239-252.
28. Kang Y., Siegel P.M., Shu W., Drobnjak M., Kakonen S.M., Cordon-Cardo C., Guise T.A., Massague J. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003, 3:537-549.
29. Kazerounian S., Gerald D., Huang M., Chin Y.R., Udayakumar D., Zheng N., O'Donnell R.K., Perruzzi C., Mangiante L., Pourat J., Phung T.L., Bravo-Nuevo A., Shechter S., McNamara S., Duhadaway J.B., Kocher O.N., Brown L.F., Toker A., Prendergast G.C., Benjamin L.E. RhoB differentially controls Akt function in tumor cells and stromal endothelial cells during breast tumorigenesis. Cancer Res. 2013, 73:50-61.
30. Lakatos H.F., Burgess H.A., Thatcher T.H., Redonnet M.R., Hernady E., Williams J.P., Sime P.J. Oropharyngeal aspiration of a silica suspension produces a superior model of silicosis in the mouse when compared to intratracheal instillation. Exp. Lung Res. 2006, 32:181-199.
31. Liu A., Cerniglia G.J., Bernhard E.J., Prendergast G.C. RhoB is required to mediate apoptosis in neoplastically transformed cells after DNA damage. Proc. Natl. Acad. Sci. U S A 2001, 98:6192-6197.
32. Liu A.X., Rane N., Liu J.P., Prendergast G.C. RhoB is dispensable for mouse development, but it modifies susceptibility to tumor formation as well as cell adhesion and growth factor signaling in transformed cells. Mol. Cell Biol. 2001, 21:6906-6912.
33. Lu X., Wang Q., Hu G., Van Poznak C., Fleisher M., Reiss M., Massague J., Kang Y. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev. 2009, 23:1882-1894.
34. Luis-Ravelo D., Anton I., Vicent S., Hernandez I., Valencia K., Zandueta C., Martinez-Canarias S., Gurpide A., Lecanda F. Tumor-stromal interactions of the bone microenvironment: in vitro findings and potential in vivo relevance in metastatic lung cancer models. Clin. Exp. Metastasis 2011, 28:779-791.
35. Luis-Ravelo D., Anton I., Zandueta C., Valencia K., Ormazabal C., Martinez-Canarias S., Guruceaga E., Perurena N., Vicent S., De Las Rivas J., Lecanda F. A gene signature of bone metastatic colonization sensitizes for tumor-induced osteolysis and predicts survival in lung cancer. Oncogene 2013, 10.1038/onc.2013.440.
36. Martini N., Bains M.S., Burt M.E., Zakowski M.F., McCormack P., Rusch V.W., Ginsberg R.J. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J. Thorac. Cardiovasc. Surg. 1995, 109:120-129.
37. Mazieres J., Antonia T., Daste G., Muro-Cacho C., Berchery D., Tillement V., Pradines A., Sebti S., Favre G. Loss of RhoB expression in human lung cancer progression. Clin. Cancer Res. 2004, 10:2742-2750.
38. Mellor H., Flynn P., Nobes C.D., Hall A., Parker P.J. PRK1 is targeted to endosomes by the small GTPase, RhoB. J. Biol. Chem. 1998, 273:4811-4814.
39. Minn A.J., Gupta G.P., Siegel P.M., Bos P.D., Shu W., Giri D.D., Viale A., Olshen A.B., Gerald W.L., Massague J., Kang Y., Serganova I., Doubrovin M., Ponomarev V., Blasberg R., Drobnjak M., Kakonen S.M., Cordon-Cardo C., Guise T.A., Cardiff R.D., Muller W.J. Genes that mediate breast cancer metastasis to lung. Nature 2005, 436:518-524.
40. Monferran S., Skuli N., Delmas C., Favre G., Bonnet J., Cohen-Jonathan-Moyal E., Toulas C. Alphavbeta3 and alphavbeta5 integrins control glioma cell response to ionising radiation through ILK and RhoB. Int. J. Cancer 2008, 123:357-364.
41. Nguyen D.X., Chiang A.C., Zhang X.H., Kim J.Y., Kris M.G., Ladanyi M., Gerald W.L., Massague J. WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell 2009, 138:51-62.
42. Prendergast G.C. Actin' up: RhoB in cancer and apoptosis. Nat. Rev. Cancer 2001, 1:162-168.
43. Prendergast G.C., Khosravi-Far R., Solski P.A., Kurzawa H., Lebowitz P.F., Der C.J. Critical role of Rho in cell transformation by oncogenic Ras. Oncogene 1995, 10:2289-2296.
44. Sato N., Fukui T., Taniguchi T., Yokoyama T., Kondo M., Nagasaka T., Goto Y., Gao W., Ueda Y., Yokoi K., Minna J.D., Osada H., Kondo Y., Sekido Y. RhoB is frequently downregulated in non-small-cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell line. Int. J. Cancer 2007, 120:543-551.
45. Skuli N., Monferran S., Delmas C., Lajoie-Mazenc I., Favre G., Toulas C., Cohen-Jonathan-Moyal E. Activation of RhoB by hypoxia controls hypoxia-inducible factor-1alpha stabilization through glycogen synthase kinase-3 in U87 glioblastoma cells. Cancer Res. 2006, 66:482-489.
46. Stewart D.J. Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer. Crit. Rev. Oncol. Hematol. 2010, 75:173-234.
47. Vega F.M., Colomba A., Reymond N., Thomas M., Ridley A.J. RhoB regulates cell migration through altered focal adhesion dynamics. Open Biol. 2012, 2:120076.
48. Vicent S., Luis-Ravelo D., Anton I., Garcia-Tunon I., Borras-Cuesta F., Dotor J., De Las Rivas J., Lecanda F. A novel lung cancer signature mediates metastatic bone colonization by a dual mechanism. Cancer Res. 2008, 68:2275-2285.
49. Witze E.S., Litman E.S., Argast G.M., Moon R.T., Ahn N.G. Wnt5a control of cell polarity and directional movement by polarized redistribution of adhesion receptors. Science 2008, 320:365-369.
50. Yang J., Mani S.A., Donaher J.L., Ramaswamy S., Itzykson R.A., Come C., Savagner P., Gitelman I., Richardson A., Weinberg R.A. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117:927-939.
51. Yin J.J., Selander K., Chirgwin J.M., Dallas M., Grubbs B.G., Wieser R., Massague J., Mundy G.R., Guise T.A. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J. Clin. Invest. 1999, 103:197-206.
52. Zhou J., Zhu Y., Zhang G., Liu N., Sun L., Liu M., Qiu M., Luo D., Tang Q., Liao Z., Zheng Y., Bi F. A distinct role of RhoB in gastric cancer suppression. Int. J. Cancer 2011, 128:1057-1068.